Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (TA 2009.40200.020)
International Society for Infectious Diseases (077166/Z/05/Z)
Text and Data Mining valid from 2019-12-01
Received: 12 July 2019
Accepted: 22 November 2019
First Online: 3 December 2019
Ethics approval and consent to participate
: The study was approved by Makerere University School of Medicine Research and Ethics Committee (REC REF 2011–175), Uganda National Drug Authority (369/ESR/NDA/DID-12/2011), Uganda National Council for Science and Technology (HS 1031) and registered with the Pan African Clinical Trial Registry (PACTR201110000321348). All study procedures were conducted according to Good Clinical Practice standards. Patients and parents or guardians of participants provided written informed consent prior to enrollment. Study related information was provided in the participants’ local languages. The dataset supporting the conclusions of this article is included in the submission as an additional file.
: “Not applicable” in this section.
: The authors declare that they have no competing interests.